Skoči na glavni sadržaj

Izvorni znanstveni članak

Attenuation of interleukin- 1β secretion in mice by post-inflammatory treatment with azithromycin and clarithromycin.

Vanesa Ivetić Tkalčević ; GSK Research Centre Zagreb Ltd., Zagreb, Croatia
Vesna Eraković Haber ; GSK Research Centre Zagreb Ltd., Zagreb, Croatia


Puni tekst: engleski pdf 178 Kb

str. 201-209

preuzimanja: 537

citiraj


Sažetak

The literature indicates that, in addition to anti-bacterial effects, certain macrolide antibiotics, such as azithromycin and clarithromycin, also exert anti-inflammatory and immunomodulatory activity, by accumulating in inflammatory cells and inhibiting the secretion of pro-inflammatory cytokines. Previous reports have shown that pre-treatment with these macrolides attenuates induced immediate skin inflammatory reactions in mice. However, the anti inflammatory activity of the post-inflammatory induction of macrolide antibiotics in this experimental model has not been investigated. The aim of this study was to explore whether the anti-inflammatory activity of azithromycin and clarithromycin, applied transdermally, 30 min after a phorbol 12-myristate 13- acetate (PMA)-induced immediate skin inflammation in mice, could attenuate a Th1 inflammatory reaction. The capacity of azithromycin and clarithromycin (500 μg/ear) to exert anti-inflammatory effects, similar to those of dexamethasone (50 μg/ear), was confirmed by the inhibition by all three agents of ear swelling and interleukin- 1β concentration in the ear tissue of PMA-treated mice, supporting this clinically relevant treatment mode.

Ključne riječi

anti-inflammatory activity; IL-1β; macrolide antibiotic; mouse; skin inflammatio

Hrčak ID:

78273

URI

https://hrcak.srce.hr/78273

Datum izdavanja:

8.3.2012.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.602 *